COMPLETED

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study will test two tactics to improve uptake of two vaccines in adults. The vaccines prevent COVID-19 and influenza. Both are common and harmful. Most adults do not get either vaccine. This is despite strong recommendations that all adults get both vaccines. The study will involve adult patients at eight Mayo Clinic primary care practices in Rochester and Kasson. The study will test the two tactics together. Four clinics will get the two tactics. The other four clinics will not. The study will randomly assign the two tactics to the clinics. One tactic is to send a letter by US mail to the patient. The letter will state strong recommendations on getting both vaccines now. It will tell patients how to get the vaccines now. The second tactic is to send monthly emails to clinicians. It will remind them to use every visit to vaccinate patients against COVID-19 and influenza. The study will compare the uptake of the two vaccines after six months in the clinics with and without the two tactics.

Official Title

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Quick Facts

Study Start:2024-10-21
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06646406

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients 19 years and older
  2. * Patients empaneled to 1 of 8 adult primary care practices as of September 2024
  1. * Patients 18 years or younger
  2. * Patients not empaneled to 1 of 8 adult primary care practices as of September 2024

Contacts and Locations

Principal Investigator

Lila J. Rutten, PhD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55902
United States
Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Lila J. Rutten, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-21
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2024-10-21
Study Completion Date2025-04-30

Terms related to this study

Keywords Provided by Researchers

  • Adult
  • Vaccination
  • Influenza vaccines
  • COVID-19 Vaccines
  • Primary Health Care
  • Reminder Systems
  • Clinician communication
  • Patient communication

Additional Relevant MeSH Terms

  • COVID-19 Immunisation
  • Influenza Vaccine